Fulcrum Therapeutics FULC 深 沪
已收盘 07-02 16:00:00 美东时间
3.84
+0.200
+5.49%
华盛通- 最 高3.85
- 今 开3.69
- 成交量 170.98万股
- 最 低 3.64
- 昨 收 3.64
- 总市值 2.56亿
- 52周最高 15.7399
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.83
- 委 比 62.60%
- 总股本 6663.33万
- 历史最高 33.098
- 量 比 0.63
- 振 幅 5.77%
- 历史最低 2.25
- 每 手 1
- 风险率 2.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Fulcrum Therapeutics Advances Restructuring with Leadership Changes
Fulcrum Therapeutics ( ($FULC) ) has provided an announcement. On May 31, 2026,...
06-12 06:21
What's Going On With Fulcrum Therapeutics Stock On Thursday?
Fulcrum Therapeutics halts pociredir development after FDA concerns over malignancy risk and begins a strategic review.
06-04 22:22
美股大行评级 | 潜在涨幅43%，慧与获11家大行集体上调目标价；最高300美元，Credo获9家大行集体上调目标价
今日重点评级关注：Ascendiant Capital：维持Genasys"买入"评级，目标价从5.5美元升至6美元；Citizens：维持Abivax"跑赢大市"评级，目标价从131美元升至187美元
06-03 11:17
Stifel Downgrades Fulcrum Therapeutics to Hold, Lowers Price Target to $3
Stifel analyst James Condulis downgrades Fulcrum Therapeutics (NASDAQ:FULC) from Buy to Hold and lowers the price target from $25 to $3.
06-03 01:57
美国Fulcrum制药公司因安全风险终止多动症新药研发 股价暴跌逾五成并寻求转让
美国生物制药公司Fulcrum Therapeutics（股票代码：FULC.O）2日宣布，因美国食品和药物管理局（FDA）对潜在致癌风险提出严重关切，公司...
06-02 21:56
Fulcrum plunges after discontinuing lead program
Fulcrum Therapeutics (FULC) lost nearly 50% of its value in extended trading after the company disclosed plans to discontinue the development of its lead asset, pociredir, for sickle cell disease in r...
06-02 18:58
BUZZ-Fulcrum falls after discontinuing sickle cell drug program
BUZZ-Fulcrum falls after discontinuing sickle cell drug program ** Shares of drug developer Fulcrum Therapeutics FULC.O fall 49.7% to $3.23 premarket ** Co said late on Monday it is discontinuing development of its experimental pociredir program for the treatment of sickle cell disease, an inherited
06-02 17:07
U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik
U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik June 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Edgewise Therapeutics, IBM and Rubrik, on Tuesday. HIGHLIGHTS * Edgewise Therapeutics Inc EWTX.O : Raymond J
06-02 15:49
美股夜盘 | 鼎信控股涨156.25%，Cheetah Net Supply Chain Service, Inc. Class A涨68.68%
Fulcrum Therapeutics涨-49.69%；Abivax SA Sponsored ADR涨-25.18%；Credo Technology涨-11.33%
06-02 08:05
Fulcrum Therapeutics Ends Pociredir, Begins Strategic Review
Fulcrum Therapeutics ( ($FULC) ) has issued an announcement. On June 1, 2026, F...
06-02 05:02
